Bowel Screening

Provision of bowel cancer screening endoscopy services, primarily colonoscopy procedures, delivered in support of the NHS Bowel Cancer Screening Programme. The contract has been awarded under the Provider Selection Regime Direct Award Process C to ensure continuity of clinically safe and effective screening services.

This procurement relates to the provision of bowel cancer screening endoscopy services primarily colonoscopy procedures delivered as part of the NHS Bowel Cancer Screening Programme. The services support the early detection of bowel cancer and the identification and removal of pre‑cancerous lesions in line with national screening standards.

The contract has been awarded under the Provider Selection Regime Direct Award Process C as the existing provider is delivering the services to a satisfactory standard and continuity of clinically safe, effective, and accessible screening services is required. the lifetime of the service is to be 1 year at a cost of £142,594.40 and will begin 01.08.26 - 31.07.26. Additional information: Maintaining uninterrupted access to bowel screening is essential for patient pathways, early detection rates, and overall service outcomes. The PSR statutory guidance highlights that continuity of service, particularly in regulated clinical pathways, is a key consideration in determining the most suitable procurement route.

The current providers at Saxon Clinic and Chiltern Clinic are already integrated into the screening pathway, workforce arrangements, booking systems, and reporting processes. Any cessation or change of provider would create gaps in delivery, resulting in cancelled appointments and reduced screening throughput.

Therefore, continuity of service was essential and supported use of Direct Award C

This contract has been awarded under

the provision of the Provider Selection

Regime (PSR). This contract has been

awarded under the Health Care

Services (Provider Selection Regime)

regulations 2023. For the avoidance of

doubt, the provision of the Public

Contracts Regulations 2015 do not

apply to this award.

The award of contract is to Circle

Health - Circle Health Group

1st Floor

30 Cannon Street

LONDON

EC4 M6X

Sub-Contract Reference Circle Health

Holdings H2 2023-2024

Direct Award C requires publication of a

notice of intention to award on the UK e

notification service, followed by an 8

working day standstill period, before

contract award.

MKUH has followed or will follow this

process in line with the PSR

transparency and accountability

requirements.

The award of contract is for 12 months.

Conflicts of interest identified among

the MKUH evaluators were none. The

ono conflicted members have assessed

the nature and risk of this conflict, and

have decided which steps to take to

avoid or manage it.

An evaluation using the PSR template

has been completed and agreed by all

evaluators.

Representations by providers must be

made to decision makers by [Add date].

This contract has not yet formally been

awarded; this notice serves as an

intention to award under the PSR.

[email protected] - responses

can be received here with the subject

title FTS-019926.

The 5 key criteria have been assessed

of 1. Quality and Innovation. 2. Value.

3. Intergration and collaboration. 4.

Improving access. 5. Social value.

This is a Provider Selection Regime

(PSR) intention to award notice. The

awarding of this contract is subject to

the Health Care Services (Provider Selection Regime) Regulations 2023.

For the avoidance of doubt, the

provisions of the Public Contracts

Regulations 2015 do not apply to this

award. The standstill period begins on

the day after the publication of this

notice. Representations by providers

must be made to the relevant authority

by [Add date]. This contract has not yet

formally been awarded; this notice

serves as an intention to award under

the PSR